Bayer | BAYN - Market Capitalization



Bayer reported EUR27.8B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
Air Liquide EUR 101.31B 10.57B Jun/2025
Akzo Nobel EUR 10.14B 464.53M Jun/2025
Alcon AG CHF 34.72B 6.87B Jun/2025
Arkema EUR 4.76B 597.08M Jun/2025
AstraZeneca GBP 215.51B 41B Jun/2025
BASF EUR 37.36B 3.6B Jun/2025
Bayer EUR 25.09B 3.38B Jun/2025
Corteva USD 50.84B 7.86B Jun/2025
Covestro EUR 11.45B 332.64M Jun/2025
Essilor EUR 106.55B 1.24B Jun/2025
Fresenius EUR 24.04B 1.84B Jun/2025
Fresenius Medical Care EUR 14.27B 870.85M Jun/2025
Genmab DKK 80.88B 7.82B Jun/2025
Givaudan CHF 36.62B 2.71B Dec/2024
GlaxoSmithKline GBP 56.24B 4.11B Jun/2025
GRIFOLS EUR 6.33B 1.14B Jun/2025
Hikma Pharmaceutical GBP 4.42B 226.35M Dec/2024
Johnson Matthey GBP 3.06B 807.29M Jun/2025
Linde EUR 195.91B 24.1B Sep/2025
Merck EUR 47.83B 7.27B Jun/2025
Novartis CHF 256.18B 64.49B Jun/2025
Nutrien CAD 28.49B 6.4B Jun/2025
Philips EUR 19.65B 2.33B Jun/2025
PPG Industries USD 25.82B 1B Jun/2025
Sanofi EUR 100.06B 25.78B Jun/2025
SAP EUR 317.14B 16.89B Jun/2025
Solvay EUR 3.07B 402.75M Jun/2025
Umicore EUR 3.08B 609.37M Jun/2025
Vinci EUR 72.79B 14.75B Jun/2025